ABBV

ABBVIE
D

ABBV

170.650
USD
1.52
(0.90%)
Market Closed
Volume
0
EPS
12
Div Yield
3.69
P/E
59
Market Cap
301,562,496,120
Signals
Related Instruments
    AMGN
    AMGN
    4.27
    (1.56%)
    277.86 USD
    BMY
    BMY
    2.065
    (3.62%)
    59.140 USD
    GSK
    GSK
    0.630
    (1.88%)
    34.070 USD
    JNJ
    JNJ
    1.340
    (0.92%)
    146.590 USD
    LLY
    LLY
    12.69
    (1.68%)
    766.55 USD
    MRK
    MRK
    0.950
    (0.99%)
    96.620 USD
    NVO
    NVO
    0.480
    (0.60%)
    81.100 USD
    PFE
    PFE
    0.410
    (1.58%)
    26.425 USD
    SNY
    SNY
    0.500
    (0.97%)
    52.000 USD
    More
News

Title: ABBVIE

Sector: Healthcare
Industry: Drug Manufacturers - General
AbbVie Inc. is an American biopharmaceutical firm that engages in research-based development, marketing and sales of pharmaceutical products. It was founded in 2011 as a spin-off of Abbott Laboratories, which planned to separate into two publicly traded companies. The new Abbott Laboratories would specialize in diversified products, including medical devices, diagnostic equipment and nutrition products, while AbbVie was slated to operate as a research-based pharmaceutical manufacturer. The separation came into effect on January 1, 2013. AbbVie was listed on the New York Stock Exchange on January 2, 2013. According to company statistics from December 2015, AbbVie Inc. employed more than 28,000 people globally and provided products to individuals in more than 170 countries. According to updated statistics from October 2022, the company now employs over 50,000 globally, reflecting impressive growth in key markets.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.